Skip to content

Peptide guide

What each compound is, whether it is approved in the United States, and what kind of research exists.

What this guide is not. It does not say what any compound does for a person, how much to use, or how to use it. It is reference reading for research purposes only. For anything about your health, talk to a licensed medical professional.

The basics

What a peptide is

A peptide is a short chain of amino acids, the same building blocks that make up proteins. Some occur naturally in the body, some are made in a laboratory, and a few are approved prescription medicines. Most of the ones people call research peptides are not approved medicines.

Approved, investigational, not approved

FDA-approved means the Food and Drug Administration reviewed trial data and allowed the product to be sold for a specific use, by prescription. Investigational means it is being tested in clinical trials. Not approved means neither: it has not been shown to the FDA to be safe and effective for any use.

How strong the evidence is

Research usually moves from the laboratory, to animals, to small human studies, to large randomized trials. A result in cells or in mice often does not hold up in people. When you read about a compound, check which of these stages the evidence comes from.

mg and mcg

A milligram (mg) is a thousandth of a gram. A microgram (mcg) is a thousandth of a milligram. So 1 mg = 1,000 mcg. Mixing the two up changes a number a thousand times, which is why the calculator asks which one you mean.

Freeze-dried powder and bac water

Research peptides usually come as a freeze-dried (lyophilized) powder in a small vial. Reconstituting means adding a measured amount of liquid to make a solution of known strength. Bacteriostatic water, often shortened to bac water, is sterile water with a small amount of benzyl alcohol added as a preservative.

Strength of the mix

Strength is the amount of powder divided by the amount of liquid: a 5 mg vial with 2 mL of water is 2.5 mg per mL. More water makes the same vial weaker per mL; less water makes it stronger.

Units on a syringe

On a U-100 insulin syringe, 100 units is 1 mL, so 10 units is 0.1 mL. Units measure how much liquid is in the syringe. They do not say how much peptide is in it: that depends on the strength of the mix.

Need the numbers worked out? Use the mix-ratio calculator.

20 compounds

  • BPC-157

    Body Protection Compound-157

    Not FDA-approved
    What it is
    A synthetic peptide of 15 amino acids, modelled on part of a protein found in stomach fluid.
    Status in the United States
    Not approved by the FDA for any use.
    Research published
    Mostly laboratory and animal studies, on soft tissue and the lining of the gut. Published human research is very limited.
  • TB-500

    Thymosin Beta-4 fragment

    Not FDA-approved
    What it is
    A synthetic peptide related to thymosin beta-4, a protein found in most human and animal cells that binds actin, one of the cell's structural proteins.
    Status in the United States
    Not approved by the FDA for any use.
    Research published
    Laboratory and animal studies of wound repair and of how cells move. Few controlled human trials.
  • GHK-Cu

    Copper peptide

    Not FDA-approved
    What it is
    A peptide of three amino acids (glycine, histidine, lysine) bound to copper. It occurs naturally in blood plasma.
    Status in the United States
    Not approved by the FDA as a drug. It is used as an ingredient in cosmetic skin products.
    Research published
    Laboratory studies of skin and collagen, and cosmetic studies of products applied to the skin.
  • Tesamorelin

    FDA-approved (prescription)
    What it is
    A synthetic version of growth hormone-releasing hormone (GHRH), the signal the brain uses to prompt the pituitary gland.
    Status in the United States
    FDA-approved as a prescription drug (brand name Egrifta) to reduce excess abdominal fat in adults with HIV who have lipodystrophy. Not approved for other uses.
    Research published
    The clinical trials behind its approval, and further studies of body composition.
  • Ipamorelin

    Not FDA-approved
    What it is
    A synthetic peptide of five amino acids that acts on the ghrelin receptor, also called the growth hormone secretagogue receptor.
    Status in the United States
    Not approved by the FDA for any use.
    Research published
    Early clinical studies, including one program on bowel recovery after surgery that did not lead to an approval.
  • CJC-1295

    With or without DAC

    Not FDA-approved
    What it is
    A synthetic, longer-lasting relative of GHRH. One form carries an added part called DAC that keeps it in the blood longer; the other form does not.
    Status in the United States
    Not approved by the FDA for any use.
    Research published
    Small early human studies that measured growth hormone and IGF-1 levels.
  • Tirzepatide

    FDA-approved (prescription)
    What it is
    A synthetic peptide that acts on two hormone receptors, GIP and GLP-1.
    Status in the United States
    FDA-approved as a prescription drug: Mounjaro for type 2 diabetes, and Zepbound for chronic weight management and for obstructive sleep apnea in adults with obesity.
    Research published
    Large clinical trial programs known as SURPASS and SURMOUNT.
  • Retatrutide

    In clinical trials, not approved
    What it is
    A synthetic peptide that acts on three hormone receptors: GIP, GLP-1 and glucagon.
    Status in the United States
    Investigational. Not approved by the FDA when this page was written; it is in late-stage clinical trials.
    Research published
    Phase 2 and phase 3 clinical trials in obesity and type 2 diabetes.
  • NAD+

    Nicotinamide adenine dinucleotide

    Not FDA-approved
    What it is
    Not a peptide. A coenzyme found in every living cell, involved in how cells turn nutrients into energy.
    Status in the United States
    Not approved by the FDA as a drug. Related compounds are sold as dietary supplements.
    Research published
    Laboratory studies and early human studies of cell energy and aging.
  • Cagrilintide

    In clinical trials, not approved
    What it is
    A synthetic, long-acting relative of amylin, a hormone the pancreas releases together with insulin.
    Status in the United States
    Investigational. Not approved by the FDA on its own; it has been studied mainly in combination with semaglutide.
    Research published
    Clinical trials in obesity and type 2 diabetes.
  • MOTS-c

    Not FDA-approved
    What it is
    A peptide of 16 amino acids whose code sits in the DNA of mitochondria, the parts of the cell that produce energy, instead of in the cell's nucleus.
    Status in the United States
    Not approved by the FDA for any use.
    Research published
    Mostly laboratory and animal studies of metabolism and exercise. Human research is at an early stage.
  • SS-31

    Elamipretide

    FDA-approved for one rare condition
    What it is
    A synthetic peptide of four amino acids that binds cardiolipin, a fat molecule in the inner membrane of mitochondria.
    Status in the United States
    The FDA granted accelerated approval in September 2025 (brand name Forzinity) for Barth syndrome, a rare genetic condition, in patients weighing at least 30 kg. Not approved for any other use.
    Research published
    Clinical trials in Barth syndrome and other conditions that involve mitochondria, and in heart failure.
  • Semax

    Not FDA-approved
    What it is
    A synthetic peptide of seven amino acids based on a fragment of the hormone ACTH.
    Status in the United States
    Not approved by the FDA. It is a registered medicine in Russia.
    Research published
    Mostly Russian clinical literature, on stroke and on thinking and memory. Little large-scale research elsewhere.
  • Selank

    Not FDA-approved
    What it is
    A synthetic peptide of seven amino acids based on tuftsin, a fragment of an immune protein.
    Status in the United States
    Not approved by the FDA. It is a registered medicine in Russia.
    Research published
    Mostly Russian clinical literature, on anxiety. Little large-scale research elsewhere.
  • ADMAX

    Adamax

    Not FDA-approved
    What it is
    A chemically modified form of Semax, sold as a research compound.
    Status in the United States
    Not approved by the FDA for any use.
    Research published
    Very little independent, peer-reviewed research has been published. Most of what is written about it comes from the companies that sell it.
  • P21

    P021

    Not FDA-approved
    What it is
    A small synthetic peptide developed from part of a nerve growth factor called CNTF.
    Status in the United States
    Not approved by the FDA for any use.
    Research published
    Animal studies of memory and of diseases that damage nerve cells. Human trial data is lacking.
  • Thymulin

    Not FDA-approved
    What it is
    A hormone of nine amino acids made by the thymus gland. It needs zinc attached to be active.
    Status in the United States
    Not approved by the FDA for any use.
    Research published
    Laboratory and animal studies of the immune system. Limited human research.
  • Thymosin Alpha-1

    TA1, thymalfasin

    Not FDA-approved
    What it is
    A peptide of 28 amino acids made naturally by the thymus gland. The synthetic form is called thymalfasin.
    Status in the United States
    Not approved by the FDA in the United States. It is approved in a number of other countries (brand name Zadaxin).
    Research published
    Clinical trials abroad, in hepatitis B and C and alongside other therapies that involve the immune system.
  • Epitalon

    Epithalon

    Not FDA-approved
    What it is
    A synthetic peptide of four amino acids, based on an extract of the pineal gland.
    Status in the United States
    Not approved by the FDA for any use.
    Research published
    Mostly Russian laboratory and animal studies of aging and of the enzyme telomerase. Human outcome data is not established.
  • Tesofensine

    In clinical trials, not approved
    What it is
    Not a peptide. A small-molecule compound that blocks the reuptake of three brain messengers: serotonin, norepinephrine and dopamine.
    Status in the United States
    Investigational. Not approved by the FDA.
    Research published
    Phase 2 clinical trials in obesity. It was first studied for Parkinson's and Alzheimer's disease.

Approval status was checked in November 2026. It changes: confirm it on the FDA’s own site before relying on it. A compound having research published about it does not mean it was shown to work or to be safe.

Where to read the evidence yourself

For research use only. This guide was written by My Peptide Shots as general reference reading. My Peptide Shots is a record-keeping and arithmetic tool for legitimate scientific research, including academic institutions, government laboratories, contract research organizations (CROs), biotech and pharmaceutical companies, and individual researchers with appropriate facilities. It is not intended for human or animal use. It is not medical advice, it does not recommend any compound, dose, schedule or site, and it is not intended to diagnose, treat, cure or prevent any disease. It has not been evaluated by the U.S. Food and Drug Administration. All users must accept the Terms of Service.